Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1989 Aug;65(766):553–558. doi: 10.1136/pgmj.65.766.553

Liver transplantation and primary biliary cirrhosis.

A K Burroughs 1, M Biagini 1, P A McCormick 1, K Rolles 1
PMCID: PMC2429510  PMID: 2690049

Full text

PDF
553

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams D. H., Ponsford S., Gunson B., Boon A., Honigsberger L., Williams A., Buckels J., Elias E., McMaster P. Neurological complications following liver transplantation. Lancet. 1987 Apr 25;1(8539):949–951. doi: 10.1016/s0140-6736(87)90294-7. [DOI] [PubMed] [Google Scholar]
  2. Adler M., Gavaler J. S., Duquesnoy R., Fung J. J., Svanas G., Starzl T. E., van Thiel D. H. Relationship between the diagnosis, preoperative evaluation, and prognosis after orthotopic liver transplantation. Ann Surg. 1988 Aug;208(2):196–202. doi: 10.1097/00000658-198808000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Babbs C., Smith A., Hunt L. P., Rowan B. P., Haboubi N. Y., Warnes T. W. Type III procollagen peptide: a marker of disease activity and prognosis in primary biliary cirrhosis. Lancet. 1988 May 7;1(8593):1021–1024. doi: 10.1016/s0140-6736(88)91843-0. [DOI] [PubMed] [Google Scholar]
  4. Beck J. R., Pauker S. G., Gottlieb J. E., Klein K., Kassirer J. P. A convenient approximation of life expectancy (the "DEALE"). II. Use in medical decision-making. Am J Med. 1982 Dec;73(6):889–897. doi: 10.1016/0002-9343(82)90787-2. [DOI] [PubMed] [Google Scholar]
  5. Beswick D. R., Klatskin G., Boyer J. L. Asymptomatic primary biliary cirrhosis. A progress report on long-term follow-up and natural history. Gastroenterology. 1985 Aug;89(2):267–271. [PubMed] [Google Scholar]
  6. Bismuth H., Castaing D., Ericzon B. G., Otte J. B., Rolles K., Ringe B., Sloof M. Hepatic transplantation in Europe. First Report of the European Liver Transplant Registry. Lancet. 1987 Sep 19;2(8560):674–676. doi: 10.1016/s0140-6736(87)92453-6. [DOI] [PubMed] [Google Scholar]
  7. Bodenheimer H. C., Jr, Schaffner F., Sternlieb I., Klion F. M., Vernace S., Pezzullo J. A prospective clinical trial of D-penicillamine in the treatment of primary biliary cirrhosis. Hepatology. 1985 Nov-Dec;5(6):1139–1142. doi: 10.1002/hep.1840050613. [DOI] [PubMed] [Google Scholar]
  8. Bodenheimer H., Jr, Schaffner F., Pezzullo J. Evaluation of colchicine therapy in primary biliary cirrhosis. Gastroenterology. 1988 Jul;95(1):124–129. doi: 10.1016/0016-5085(88)90300-9. [DOI] [PubMed] [Google Scholar]
  9. Christensen E., Neuberger J., Crowe J., Altman D. G., Popper H., Portmann B., Doniach D., Ranek L., Tygstrup N., Williams R. Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial. Gastroenterology. 1985 Nov;89(5):1084–1091. doi: 10.1016/0016-5085(85)90213-6. [DOI] [PubMed] [Google Scholar]
  10. Christensen E., Schlichting P., Andersen P. K., Fauerholdt L., Schou G., Pedersen B. V., Juhl E., Poulsen H., Tygstrup N. Updating prognosis and therapeutic effect evaluation in cirrhosis with Cox's multiple regression model for time-dependent variables. Scand J Gastroenterol. 1986 Mar;21(2):163–174. doi: 10.3109/00365528609034642. [DOI] [PubMed] [Google Scholar]
  11. Cuervas-Mons V., Millan I., Gavaler J. S., Starzl T. E., Van Thiel D. H. Prognostic value of preoperatively obtained clinical and laboratory data in predicting survival following orthotopic liver transplantation. Hepatology. 1986 Sep-Oct;6(5):922–927. doi: 10.1002/hep.1840060519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dickson E. R., Fleming T. R., Wiesner R. H., Baldus W. P., Fleming C. R., Ludwig J., McCall J. T. Trial of penicillamine in advanced primary biliary cirrhosis. N Engl J Med. 1985 Apr 18;312(16):1011–1015. doi: 10.1056/NEJM198504183121602. [DOI] [PubMed] [Google Scholar]
  13. Epstein O., Jain S., Lee R. G., Cook D. G., Boss A. M., Scheuer P. J., Sherlock S. D-penicillamine treatment improves survival in primary biliary cirrhosis. Lancet. 1981 Jun 13;1(8233):1275–1277. doi: 10.1016/s0140-6736(81)92456-9. [DOI] [PubMed] [Google Scholar]
  14. Eriksson S., Zettervall O. The N-terminal propeptide of collagen type III in serum as a prognostic indicator in primary biliary cirrhosis. J Hepatol. 1986;2(3):370–378. doi: 10.1016/s0168-8278(86)80048-4. [DOI] [PubMed] [Google Scholar]
  15. Esquivel C. O., Van Thiel D. H., Demetris A. J., Bernardos A., Iwatsuki S., Markus B., Gordon R. D., Marsh J. W., Makowka L., Tzakis A. G. Transplantation for primary biliary cirrhosis. Gastroenterology. 1988 May;94(5 Pt 1):1207–1216. doi: 10.1016/0016-5085(88)90014-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Goudie B. M., Burt A. D., Boyle P., Macfarlane G., Birnie G. G., Mills P. R., Gillis C. R., MacSween R. N., Watkinson G. Breast cancer in women with primary biliary cirrhosis. Br Med J (Clin Res Ed) 1985 Dec 7;291(6509):1597–1598. doi: 10.1136/bmj.291.6509.1597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Haagsma E. B., Manns M., Klein R., Grond J., Huizenga J. R., Slooff M. J., Meyer zum Büschenfelde K. H., Berg P. A., Gips C. H. Subtypes of antimitochondrial antibodies in primary biliary cirrhosis before and after orthotopic liver transplantation. Hepatology. 1987 Jan-Feb;7(1):129–133. doi: 10.1002/hep.1840070125. [DOI] [PubMed] [Google Scholar]
  18. Heathcote J., Ross A., Sherlock S. A prospective controlled trial of azathioprine in primary biliary cirrhosis. Gastroenterology. 1976 May;70(5 PT1):656–660. [PubMed] [Google Scholar]
  19. Hoofnagle J. H., Davis G. L., Schafer D. F., Peters M., Avigan M. I., Pappas S. C., Hanson R. G., Minuk G. Y., Dusheiko G. M., Campbell G. Randomized trial of chlorambucil for primary biliary cirrhosis. Gastroenterology. 1986 Dec;91(6):1327–1334. doi: 10.1016/0016-5085(86)90183-6. [DOI] [PubMed] [Google Scholar]
  20. Iwatsuki S., Gordon R. D., Shaw B. W., Jr, Starzl T. E. Role of liver transplantation in cancer therapy. Ann Surg. 1985 Oct;202(4):401–407. doi: 10.1097/00000658-198510000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. James O., Macklon A. F., Watson A. J. Primary biliary cirrhosis--a revised clinical spectrum. Lancet. 1981 Jun 13;1(8233):1278–1281. doi: 10.1016/s0140-6736(81)92457-0. [DOI] [PubMed] [Google Scholar]
  22. James S. P., Hoofnagle J. H., Strober W., Jones E. A. NIH conference: Primary biliary cirrhosis: a model autoimmune disease. Ann Intern Med. 1983 Oct;99(4):500–512. doi: 10.7326/0003-4819-99-4-500. [DOI] [PubMed] [Google Scholar]
  23. Kaplan M. M., Alling D. W., Zimmerman H. J., Wolfe H. J., Sepersky R. A., Hirsch G. S., Elta G. H., Glick K. A., Eagen K. A. A prospective trial of colchicine for primary biliary cirrhosis. N Engl J Med. 1986 Dec 4;315(23):1448–1454. doi: 10.1056/NEJM198612043152304. [DOI] [PubMed] [Google Scholar]
  24. Kaplan M. M. Primary biliary cirrhosis. N Engl J Med. 1987 Feb 26;316(9):521–528. doi: 10.1056/NEJM198702263160907. [DOI] [PubMed] [Google Scholar]
  25. Kassirer J. P., Moskowitz A. J., Lau J., Pauker S. G. Decision analysis: a progress report. Ann Intern Med. 1987 Feb;106(2):275–291. doi: 10.7326/0003-4819-106-2-275. [DOI] [PubMed] [Google Scholar]
  26. Lucey M. R., Neuberger J. M., Williams R. Primary biliary cirrhosis in men. Gut. 1986 Nov;27(11):1373–1376. doi: 10.1136/gut.27.11.1373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Maddrey W. C., Van Thiel D. H. Liver transplantation: an overview. Hepatology. 1988 Jul-Aug;8(4):948–959. doi: 10.1002/hep.1840080440. [DOI] [PubMed] [Google Scholar]
  28. Matloff D. S., Alpert E., Resnick R. H., Kaplan M. M. A prospective trial of D-penicillamine in primary biliary cirrhosis. N Engl J Med. 1982 Feb 11;306(6):319–326. doi: 10.1056/NEJM198202113060602. [DOI] [PubMed] [Google Scholar]
  29. Matloff D. S., Kaplan M. M., Neer R. M., Goldberg M. J., Bitman W., Wolfe H. J. Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment. Gastroenterology. 1982 Jul;83(1 Pt 1):97–102. [PubMed] [Google Scholar]
  30. McNeil B. J., Weichselbaum R., Pauker S. G. Fallacy of the five-year survival in lung cancer. N Engl J Med. 1978 Dec 21;299(25):1397–1401. doi: 10.1056/NEJM197812212992506. [DOI] [PubMed] [Google Scholar]
  31. Melia W. M., Johnson P. J., Neuberger J., Zaman S., Portmann B. C., Williams R. Hepatocellular carcinoma in primary biliary cirrhosis: detection by alpha-fetoprotein estimation. Gastroenterology. 1984 Sep;87(3):660–663. [PubMed] [Google Scholar]
  32. Minuk G. Y., Bohme C. E., Burgess E., Hershfield N. B., Kelly J. K., Shaffer E. A., Sutherland L. R., Van Rosendaal G. Pilot study of cyclosporin A in patients with symptomatic primary biliary cirrhosis. Gastroenterology. 1988 Nov;95(5):1356–1363. doi: 10.1016/0016-5085(88)90373-3. [DOI] [PubMed] [Google Scholar]
  33. Neuberger J., Christensen E., Portmann B., Caballeria J., Rodes J., Ranek L., Tygstrup N., Williams R. Double blind controlled trial of d-penicillamine in patients with primary biliary cirrhosis. Gut. 1985 Feb;26(2):114–119. doi: 10.1136/gut.26.2.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Nyberg A., Engström-Laurent A., Löf L. Serum hyaluronate in primary biliary cirrhosis--a biochemical marker for progressive liver damage. Hepatology. 1988 Jan-Feb;8(1):142–146. doi: 10.1002/hep.1840080127. [DOI] [PubMed] [Google Scholar]
  35. O'Grady J. G., Polson R. J., Rolles K., Calne R. Y., Williams R. Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg. 1988 Apr;207(4):373–379. doi: 10.1097/00000658-198804000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Pauker S. G., Kassirer J. P. Decision analysis. N Engl J Med. 1987 Jan 29;316(5):250–258. doi: 10.1056/NEJM198701293160505. [DOI] [PubMed] [Google Scholar]
  37. Portmann B., Popper H., Neuberger J., Williams R. Sequential and diagnostic features in primary biliary cirrhosis based on serial histologic study in 209 patients. Gastroenterology. 1985 Jun;88(6):1777–1790. doi: 10.1016/0016-5085(85)90001-0. [DOI] [PubMed] [Google Scholar]
  38. Rimola A., Gavaler J. S., Schade R. R., el-Lankany S., Starzl T. E., Van Thiel D. H. Effects of renal impairment on liver transplantation. Gastroenterology. 1987 Jul;93(1):148–156. doi: 10.1016/0016-5085(87)90327-1. [DOI] [PubMed] [Google Scholar]
  39. Rubel L. R., Rabin L., Seeff L. B., Licht H., Cuccherini B. A. Does primary biliary cirrhosis in men differ from primary biliary cirrhosis in women? Hepatology. 1984 Jul-Aug;4(4):671–677. doi: 10.1002/hep.1840040418. [DOI] [PubMed] [Google Scholar]
  40. SHERLOCK S. Primary billiary cirrhosis (chronic intrahepatic obstructive jaundice). Gastroenterology. 1959 Nov;37:574–586. [PubMed] [Google Scholar]
  41. Shapiro J. M., Smith H., Schaffner F. Serum bilirubin: a prognostic factor in primary biliary cirrhosis. Gut. 1979 Feb;20(2):137–140. doi: 10.1136/gut.20.2.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Sherlock S., Scheuer P. J. The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med. 1973 Sep 27;289(13):674–678. doi: 10.1056/NEJM197309272891306. [DOI] [PubMed] [Google Scholar]
  43. Smith N. D., Boyer J. L. Are antimitochondrial antibodies of prognostic value in primary biliary cirrhosis? Hepatology. 1986 Jul-Aug;6(4):739–741. doi: 10.1002/hep.1840060433. [DOI] [PubMed] [Google Scholar]
  44. Taal B. G., Schalm S. W., Ten Kate F. W., Van Berge Henegouwen G. P., Brandt K. H. Low therapeutic value of D-penicillamine in a short-term prospective trial in primary biliary cirrhosis. Liver. 1983 Dec;3(6):345–352. doi: 10.1111/j.1600-0676.1983.tb00887.x. [DOI] [PubMed] [Google Scholar]
  45. Van Thiel D. H., Gavaler J. S. Recurrent disease in patients with liver transplantation: when does it occur and how can we be sure? Hepatology. 1987 Jan-Feb;7(1):181–183. doi: 10.1002/hep.1840070133. [DOI] [PubMed] [Google Scholar]
  46. Warnes T. W., Smith A., Lee F. I., Haboubi N. Y., Johnson P. J., Hunt L. A controlled trial of colchicine in primary biliary cirrhosis. Trial design and preliminary report. J Hepatol. 1987 Aug;5(1):1–7. doi: 10.1016/s0168-8278(87)80053-3. [DOI] [PubMed] [Google Scholar]
  47. Wiesner R. H., Grambsch P. M., Lindor K. D., Ludwig J., Dickson E. R. Clinical and statistical analyses of new and evolving therapies for primary biliary cirrhosis. Hepatology. 1988 May-Jun;8(3):668–676. doi: 10.1002/hep.1840080339. [DOI] [PubMed] [Google Scholar]
  48. Wolke A. M., Schaffner F., Kapelman B., Sacks H. S. Malignancy in primary biliary cirrhosis. High incidence of breast cancer in affected women. Am J Med. 1984 Jun;76(6):1075–1078. doi: 10.1016/0002-9343(84)90861-1. [DOI] [PubMed] [Google Scholar]
  49. Wood R. P., Shaw B. W., Jr, Starzl T. E. Extrahepatic complications of liver transplantation. Semin Liver Dis. 1985 Nov;5(4):377–384. doi: 10.1055/s-2008-1040636. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES